Enhanced fluorogenic endoluminal filter structure
US-2016175085-A1 · Jun 23, 2016 · US
US11845846B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11845846-B2 |
| Application number | US-201816642205-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 4, 2018 |
| Priority date | Sep 4, 2017 |
| Publication date | Dec 19, 2023 |
| Grant date | Dec 19, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A flowable liquid formulation for 3D printing is described. The formulation comprises from 0.1 to 25 wt. % radiopaque particles, wherein at least 50% by weight of the particles have a diameter of at most 100 nm. The formulation further comprises monomeric, oligomeric and/or polymeric precursors adapted for polymerization to form a solidified article. Also described is an article (100) formed by 3D printing, the article (100) comprising a first 3D printed region (110) having a first radiopacity and a second 3D printed region (120) having a second radiopacity, wherein the first radiopacity is greater than the second radiopacity. Also described is a method of forming the article (100).
Opening claim text (preview).
The invention claimed is: 1. A flowable liquid formulation for 3D printing a solidified article having a radiopacity of at least 200 HU up to 1200 HU, the flowable liquid formulation comprising: from 0.1 to 25 wt. % radiopaque particles, wherein at least 50% of the particles have a diameter of at most 100 nm; and monomeric, oligomeric and/or polymeric precursors adapted for polymerization to form the solidified article; wherein the flowable liquid formulation comprises from 5 to 80 wt. % oligomeric precursors; and wherein the dynamic viscosity, measured at 20° C., of the flowable liquid formulation is in a range from 100 to 1000 centipoise. 2. The flowable liquid formulation according to claim 1 comprising from 5 to 10 wt. % radiopaque particle. 3. The flowable liquid formulation according to claim 1 wherein the radiopaque particles comprise ZrO 2 particles, Nb 2 O 5 particles, Ta 2 O 5 particles and/or silver acetate (CH 3 CO 2 Ag) particles. 4. The flowable liquid formulation according to claim 1 comprising from 40 to 80 wt. % monomeric, oligomeric and/or polymeric precursors. 5. The flowable liquid formulation according to claim 1 comprising from 20 to 60 wt. % monomeric precursors. 6. The flowable liquid formulation according to claim 1 comprising at least one of a photoinitiator, a retarder solvent, a filler and a colouring agent. 7. An article formed by 3D printing, the article having a radiopacity of at least 200 HU up to 1200 HU, the article comprising a first 3D printed region having a first radiopacity and a second 3D printed region having a second radiopacity, wherein the first radiopacity is greater than the second radiopacity, wherein the first 3D printed region is obtained by polymerisation of the formulation according to claim 1 . 8. The article according to claim 7 , wherein the artic a calibration standard for a medical radiography apparatus. 9. The article according to claim 7 , wherein the article is a medical device.
of metals · CPC title
using calibration phantoms · CPC title
Other inorganic materials not covered by A61L31/022 - A61L31/026 · CPC title
Materials at least partially X-ray or laser opaque · CPC title
using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.